Todo DSpace

HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT

Thumbnail
Autor
Goulis, L.; Akriviadis, E.; Karatapanis, S.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M. P.; Drakoulis, C.; Mimidis, K.; Germanidis, G.; Nikolopoulou, V.; Chounta, A.; Bakalos, G.; Papatheodoridis, G. V.
Fecha
2011
Materia
Mostrar el registro completo del ítem
URI
http://hdl.handle.net/11615/28109
Colecciones